Alembic Aripiprazole Tablets 2mg Recall: Label Mix-Up With 5mg Tablets
Alembic Pharmaceuticals recalls 2mg aripiprazole tablets due to label mix-up with 5mg tablets. This could lead to incorrect dosing if taken without proper label check.
Lower-risk recall
Labeling: Label mix up: Bottles labeled as aripiprazole 2 mg, 30 count had aripiprazole 5 mg tablets, 100 count.
Contact the company
What happened, in plain English
Alembic Pharmaceuticals is recalling 2mg aripiprazole tablets that were mislabeled as 2mg but contain 5mg tablets. This risk of incorrect dosing could cause harm if taken without checking the label. Read more at govinfonow.com/recall/37058-alembic-aripiprazole-tablets-2mg-recall-label-mix-up-with-5mg.
Source Summary by GovInfoNow · govinfonow.com/recall/37058-alembic-aripiprazole-tablets-2mg-recall-label-mix-up-with-5mg · Updated October 5, 2026 · FDA enforcement record: FDA #D-1341-2020
Cite this page
“Alembic Aripiprazole Tablets 2mg Recall: Label Mix-Up With 5mg Tablets.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37058-alembic-aripiprazole-tablets-2mg-recall-label-mix-up-with-5mg. Based on FDA recall #D-1341-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1341-2020%22&limit=1).
Why it’s dangerous
The tablets were labeled as 2mg but contain 5mg tablets. If taken without checking the label, patients could receive a higher dose than intended, potentially causing side effects.
Who’s affected
Prescription patients who received the recalled 2mg aripiprazole tablets with 5mg tablets inside. Those at highest risk are patients taking the medication for mental health conditions.
How to tell if you have this one
Check for bottles labeled 'Aripiprazole 2 mg, 30 Tablets per bottle' with the lot number 1905003298, manufactured in India and distributed by Alembic Pharmaceuticals, Inc. in the US.
- Brand
Alembic Pharmaceuticals- Category
Drug
What to do — step by step
Check Label Carefully
Look for the label indicating 5mg tablets inside a bottle marked as 2mg.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in the U.S.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 19 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
What should I do if I have the recalled product?
Check the label carefully to ensure you have 2mg tablets. If you find 5mg tablets inside a 2mg-labeled bottle, contact your doctor or pharmacist.
Similar recalls
Other Alembic Pharmaceuticals recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1341-2020 (June 10, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1341-2020 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.